A mathematical model for the effects of HER2 overexpression on cell proliferation in breast cancer

被引:21
作者
Eladdadi, Amina [1 ]
Isaacson, David [1 ]
机构
[1] Rensselaer Polytech Inst, Dept Math Sci, Troy, NY 12180 USA
关键词
HER2; cell proliferation; receptor modeling; mathematical modeling;
D O I
10.1007/s11538-008-9315-4
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We present a mathematical model to study the effects of HER2 over-expression on cell proliferation in breast cancer. The model illustrates the proliferative behavior of cells as a function of HER2 and EGFR receptors numbers, and the growth factor EGF. This mathematical model comprises kinetic equations describing the cell surface binding of EGF growth factor to EGFR and HER2 receptors, coupled to a model for the dependence of cell proliferation rate on growth factor receptors binding. The simulation results from this model predict: (1) a growth advantage associated with excess HER2 receptors; (2) that HER2-over-expression is an insufficient parameter to predict the proliferation response of cancer cells to epidermal growth factors; and (3) the EGFR receptor expression level in HER2-over-expressing cells plays a key role in mediating the proliferation response to receptor-ligand signaling. This mathematical model also elucidates the interaction and roles of other model parameters in determining cell proliferation rate of HER2-over-expressing cells.
引用
收藏
页码:1707 / 1729
页数:23
相关论文
共 38 条
  • [1] The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions
    Alroy, I
    Yarden, Y
    [J]. FEBS LETTERS, 1997, 410 (01) : 83 - 86
  • [2] HER2/Neu: mechanisms of dimerization/oligomerization
    Brennan, PJ
    Kumogai, T
    Berezov, A
    Murali, R
    Greene, MI
    [J]. ONCOGENE, 2000, 19 (53) : 6093 - 6101
  • [3] A NEU ACQUAINTANCE FOR ERBB3 AND ERBB4 - A ROLE FOR RECEPTOR HETERODIMERIZATION IN GROWTH SIGNALING
    CARRAWAY, KL
    CANTLEY, LC
    [J]. CELL, 1994, 78 (01) : 5 - 8
  • [4] CLARK GM, 1991, CANCER RES, V51, P944
  • [5] ERBB-2 IS A POTENT ONCOGENE WHEN OVEREXPRESSED IN NIH/3T3 CELLS
    DIFIORE, PP
    PIERCE, JH
    KRAUS, MH
    SEGATTO, O
    KING, CR
    AARONSON, SA
    [J]. SCIENCE, 1987, 237 (4811) : 178 - 182
  • [6] ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
    GrausPorta, D
    Beerli, RR
    Daly, JM
    Hynes, NE
    [J]. EMBO JOURNAL, 1997, 16 (07) : 1647 - 1655
  • [7] Harris RA, 1999, INT J CANCER, V80, P477, DOI 10.1002/(SICI)1097-0215(19990129)80:3<477::AID-IJC23>3.0.CO
  • [8] 2-W
  • [9] The growth law of primary breast cancer as inferred from mammography screening trials data
    Hart, D
    Shochat, E
    Agur, Z
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 (03) : 382 - 387
  • [10] Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis - Distribution of homo- and heterodimers depends on relative HER2 levels
    Hendriks, BS
    Opresko, LK
    Wiley, HS
    Lauffenburger, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (26) : 23343 - 23351